6TOV

Crystal Structure of Teicoplanin Aglycone


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 0.77 Å
  • R-Value Free: 0.114 
  • R-Value Work: 0.097 
  • R-Value Observed: 0.097 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase

Bolognino, I.Carrieri, A.Purgatorio, R.Catto, M.Caliandro, R.Carrozzini, B.Belviso, B.D.Majellaro, M.Sotelo, E.Cellamare, S.Altomare, C.D.

(2022) Separations 


Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Teicoplanin AglyconeA7synthetic constructMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Modified Residues  2 Unique
IDChainsTypeFormula2D DiagramParent
3MY
Query on 3MY
A D-PEPTIDE LINKINGC9 H10 Cl N O3TYR
OMY
Query on OMY
A L-PEPTIDE LINKINGC9 H10 Cl N O4TYR
Biologically Interesting Molecules (External Reference) 1 Unique
Entity ID: 1
IDChainsNameType/Class2D Diagram3D Interactions
PRD_000210
Query on PRD_000210
ATeicoplanin AglyconeOligopeptide / Antibiotic Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 0.77 Å
  • R-Value Free: 0.114 
  • R-Value Work: 0.097 
  • R-Value Observed: 0.097 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 35.722α = 90
b = 13.113β = 123.34
c = 21.717γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
Aimlessdata scaling
Sir2014phasing

Structure Validation

View Full Validation Report




Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2020-01-15
    Type: Initial release
  • Version 1.1: 2022-01-19
    Changes: Database references, Derived calculations